Cancer prevention agent development program: early phase clinical research - core infrastructure support

Ended Awarded Last action

Contract number
HHSN26100001
Awardee
Awarding agency
Obligated
$0

Award facts

Opportunity
  • N01CN0501469 Solicitation number
Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Rochester, MN 55905, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 3 -$550,995
Other Administrative Action 2 $0
Other Administrative Action 1 · Other functions core infrastructure support for cancer prevention agent development program: early phase clinical research. $0
Original award $550,995

Quick answers

Who was awarded contract HHSN26100001?

HHSN26100001 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 24, 2012.

How much is contract HHSN26100001 worth?

The government has obligated $0 on HHSN26100001.

Is contract HHSN26100001 an order under another contract?

Yes. HHSN26100001 is a delivery order under HHSN261201200032I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN26100001 competed?

The extent of competition for HHSN26100001 was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award